Preclinical evaluation of haemosorbents

Area of Science:

• Biomedical Engineering
• Toxicology
• Regenerative Medicine

Background:

• Preclinical evaluation of haemosorbents is crucial for developing effective medical devices.
• Understanding the relationship between assessment procedures and intended applications ensures accurate device validation.
• Artificial liver support systems require robust preclinical testing to assess haemosorbent performance.

Purpose of the Study:

• To describe and exemplify assessment procedures for haemosorbent preclinical evaluation using rat models.
• To demonstrate the relevance of these procedures to intended applications, specifically artificial liver support.
• To investigate the link between haemosorbent properties and liver regeneration.

Main Methods:

• Development and utilization of assessment procedures in rats, including haemoperfusion and plasma perfusion.
• Procedures designed for single or repeated use in unrestrained, conscious animals.
• Extracorporeal circuits in rats used to evaluate sorbent properties and liver regeneration post-partial hepatectomy.

Main Results:

• Established rat-based procedures for preclinical haemosorbent evaluation, suitable for conscious, unrestrained animals.
• Demonstrated the utility of these procedures in assessing artificial liver support efficacy.
• Provided insights into the relationship between sorbent characteristics and liver regenerative capacity.

Conclusions:

• Rat models provide a relevant platform for preclinical haemosorbent assessment, mirroring intended clinical applications.
• The described procedures effectively link haemosorbent properties to outcomes in artificial liver support and liver regeneration.
• Careful selection of assessment methods is critical for validating haemosorbents for specific medical uses.